Application of Compounds with Anti‐Cardiac Fibrosis Activity: A Review

Yu-Qing Meng,Xun Cui,Siqi Li,Cheng-Hua Jin
DOI: https://doi.org/10.1002/cbdv.202401078
2024-09-04
Chemistry & Biodiversity
Abstract:Coronary heart disease, hypertension, myocarditis, and valvular disease cause myocardial fibrosis, leading to heart enlargement, heart failure, heart rate failure, arrhythmia, and premature ventricular beat, even defibrillation can increase the risk of sudden death. Although cardiac fibrosis is common and widespread, there are still no effective drugs to provide adequate clinical intervention for cardiac fibrosis. In this review article, we classify the compounds for treating cardiac fibrosis into natural products, synthetic compounds, and patent drugs according to their sources. Additionally, the structures, activities and signaling pathways of these compounds are discussed. This review provides insight and could provide a reference for the design of new anti‐cardiac fibrosis compounds and the new use of older drugs.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?